UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported)
| (Exact name of registrant as specified in its charter) |
| (State or other jurisdiction of | (Commission | (IRS Employer | ||
| incorporation) | File Number) | Identification No.) |
| (Address of principal executive offices) |
Registrant’s
telephone number, including area code
__________________________________________
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| None | None | None |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this Chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this Chapter).
Emerging
Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement
On October 7, 2026, Verde Resources, Inc. (the “Company”) commenced a private placement offering (the “Offering”) to accredited investors of up to $5.0 million of the Company’s common stock (“Common Stock”), with no aggregate minimum offering amount. The Offering is currently scheduled to remain open through December 14, 2026.
In connection with the Offering, each investor will enter into a securities purchase agreement (an “SPA”) in the form as filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. Pursuant to the terms of the SPA, the price per share is calculated using a 10-day volume-weighted average price through the trading day immediately preceding the execution of the respective SPA, provided however in the case that the aggregate subscription amount by an investor exceeds $50,000, such price per share will equal 90% of such 10-day volume-weighted average price. The SPA requires that each investor and either Mr. Jack Wong, our Chief Executive Officer and Chairman, or Mr. Eric Bava, our Chief Operating Officer and Director, enter into a Collateralization Agreement (as defined and discussed below) as a condition to the closing of each investment. The SPA additionally includes certain customary closing conditions, as well as customary representations, warranties and covenants by the Company and the investors, including indemnification by each of the Company and the investor to the opposite party. The representations, warranties and covenants contained in the SPA were made only for purposes of such SPA and are made as of specific dates; are solely for the benefit of the parties (except as specifically set forth therein); may be subject to qualifications and limitations agreed upon by the parties in connection with negotiating the terms of the SPA, instead of establishing matters as facts; and may be subject to standards of materiality and knowledge applicable to the contracting parties that differ from those applicable to the investors generally. Investors should not rely on the representations, warranties and covenants or any description thereof as characterizations of the actual state of facts or condition of the Company.
The Offering is exempt from the registration requirements of the Securities Act pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable state laws. The Purchasers represented that they were accredited investors within the meaning of Rule 501(a) of Regulation D and were acquiring the securities as principal for their own accounts and not with a view to or for distributing or reselling the securities. The securities were offered without any general solicitation by the Company or its representatives. The securities sold and issued in the Offering will not be registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from the registration requirements.
The foregoing description of the SPA is qualified in its entirety by reference to the text of such agreement, the form of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 3.02. Unregistered Sales of Equity Securities.
The disclosures set forth in Item 1.01 above are incorporated by reference into this Item 3.02. As of November 16, 2026, the Company had issued an aggregate of 21,132,429 shares of Common Stock in exchange for aggregate gross proceeds of $600,000 in connection with the Offering. The terms of the three closings under the Offering made to date are as follows:
| ● | On October 12, 2026, the Company sold 1,945,525 shares of Common Stock to an accredited investor at a price of $0.0257, per share for gross proceeds of $50,000. |
| ● | On October 12, 2026, the Company sold 1,945,525 shares of Common Stock to an accredited investor at a price of $0.0257 per share, for gross proceeds of $50,000. |
| ● | On November 16, 2026, the Company sold 17,241,379 shares of Common Stock to an accredited investor at a price of $0.029 per share, for gross proceeds of $500,000. |
The proceeds from the Offering are intended to be used for general operating and working capital purposes.
| 2 |
Item 8.01 Other Events.
In connection with, and as a condition to the closing of, the Offering, each investor who participates in the Offering has or will have entered into separate share collateralization agreements (the “Collateralization Agreements”) with either Mr. Jack Wong or Mr. Eric Bava, in each of Mr. Wong’s and Mr. Bava’s personal capacity. Pursuant to the terms of the Collateralization Agreements, after a period of six months have elapsed, if the aggregate market value of an investor’s shares of Common Stock at the end of such six month period is less than the investor’s original aggregate investment amount purchased in the Offering (such difference, a “Shortfall”), either Jack Wong or Eric Bava, as applicable, will provide the investor with such number of their personally held shares of Common Stock to cover such Shortfall. In the case that the aggregate market value of an investor’s shares of Common Stock at the end of such six month period is the same as or more than the investor’s original aggregate investment amount purchased in the Offering, and therefore no Shortfall exists, then neither Jack Wong or Eric Bava will be required to provide an shares of Common Stock to such investor, and the respective Collateralization Agreement will automatically terminate in accordance with its terms.
The foregoing description of the Collateralization Agreements is qualified in its entirety by reference to the text of such agreements, the form of which is filed as Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference.
Cautionary Note Regarding Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements that fall within the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors, including those regarding the Offering, Collateralization Agreements, and potential Shortfalls, which may cause the results of the Company to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are included in documents the Company files with the Securities and Exchange Commission (the “SEC”), including but not limited to, the Company’s Annual Report on Form 10-K for the year ended June 30, 2026, as well as subsequent reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included in this Current Report on Form 8-K are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company expressly disclaims any intent or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
The following exhibits are being filed herewith:
| Exhibit No. | Description | |
| 10.1 | Form of Securities Purchase Agreement | |
| 10.2 | Form of Share Collateralization Agreement | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL documents) |
| 3 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Verde Resources, Inc. | ||
| By: | /s/ Jack Wong | |
| Name: | Jack Wong | |
| Title: | Chief Executive Officer | |
| Dated: November 20, 2026 | ||
| 4 |